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CCR2After traumatic spinal cord injury, functional deﬁcits increase as axons die back from the center of the lesion and
the glial scar forms. Axonal dieback occurs in two phases: an initial axon intrinsic stage that occurs over the ﬁrst
several hours and a secondary phase which takes place over the ﬁrst few weeks after injury. Here, we examine
the secondary phase, which is marked by inﬁltration of macrophages. Using powerful time-lapse multi-photon
imaging, we captured images of interactions between Cx3cr1+/GFP macrophages and microglia and Thy-1YFP
axons in a mouse dorsal column crush spinal cord injury model. Over the ﬁrst few weeks after injury, axonal
retraction bulbs within the lesion are static except when axonal fragments are lost by a blebbing mechanism
in response to physical contact followed by phagocytosis bymobile Cx3Cr1+/GFP cells. Utilizing a radiation chime-
ra model to distinguish marrow-derived cells from radio-resistant CNS-resident microglia, we determined that
the vast majority of accumulated cells in the lesion are derived from the blood and only these are associated
with axonal damage. Interestingly, CNS-resident Cx3Cr1+/GFP microglia did not increasingly accumulate nor
participate in neuronal destruction in the lesion during this time period. Additionally, we found that the blood-
derived cells consisted mainly of singly labeled Ccr2+/RFP macrophages, singly labeled Cx3Cr1+/GFP macrophages
and a small population of double-labeled cells. Since all axon destructive events were seen in contact with a
Cx3Cr1+/GFP cell, we infer that the CCR2 single positive subset is likely not robustly involved in axonal dieback.
Finally, in our model, deletion of CCR2, a chemokine receptor, did not alter the position of axons after dieback.
Understanding the in vivo cellular interactions involved in secondary axonal injurymay lead to clinical treatment
candidates involving modulation of destructive inﬁltrating blood monocytes.
© 2014 The Authors. Published by Elsevier Inc. All rights reserved. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Axons severed by traumatic injury not only fail to regrow but retract
from the center of the lesion over the ﬁrst few weeks after injury.
Retracting axonal endings form a variety of unusually shaped tipsell Road, Cleveland, OH 44106-
eland, OH 44106, USA. Fax: +1
deborah.sim@case.edu
@laurelschool.org (E.G. Hare),
off), ayh3@case.edu
ll rights reserved. This is anopenacces(Busch et al., 2009; Kerschensteiner et al., 2005) which Ramon y Cajal
described as retraction clubs, linking their anatomy to their unusual
dying back behavior (Cajal, 1907). Over the ﬁrst few hours after injury,
the early phase of retraction occurs by a neuron intrinsic mechanism
with axonal beading and rapid dissolution of the distal axon segment
(Kerschensteiner et al., 2005). In the subsequent days and weeks
following injury a less well described secondary period of dieback
occurs which is correlated with inﬁltration of blood-derived immune
cells, including macrophages (Busch et al., 2009; Fitch and Silver,
2008). The role of these macrophages in the lesion has been controver-
sial, with evidence that these cells are both beneﬁcial (Schwartz and
Yoles, 2006; Shechter et al., 2009, 2013) as well as destructive (Busch
et al., 2009; Donnelly and Popovich, 2008; Fitch and Silver, 2008; Hsu
et al., 2006; Popovich et al., 1999).
It is well known that the secondary period of dieback can be inﬂu-
enced by depleting circulating phagocytic cells, including macrophagess article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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cells, cause their death by apoptosis (Van Rooijen and Sanders, 1994). In
macrophage depleted animals, there was no further change in axonal
position beyond that which occurred initially, strongly implicating
macrophages in the delayed dieback phenomenon (Horn et al., 2008).
Decrease in dieback has also been shown in minocycline treated rats
with a reduced macrophage response (McPhail et al., 2004). The de-
structive interaction between inﬂammatory cells and dystrophic axons
was further corroborated by in vitro studies showing that activated
macrophages can cause striking retraction of dystrophic axons in a
contact-dependent manner, while cultured microglia had a lesser effect
(Busch et al., 2009). In culture, axonal retraction after contact with acti-
vated macrophages could be inhibited by functionally blocking MMP9
but not MMP2 (Busch et al., 2009). Although much is known about
the requirement for macrophages in this phenomenon, very little is
known about how these cells actually interact in vivo.
The population of phagocytic immune cells found in the CNS is
heterogeneous and comprised predominantly of two groups:
specialized CNS-resident microglia and inﬁltrating macrophages.
Microglial cells arrive in the CNS from the yolk sack in development
(Ginhoux et al., 2010; Kierdorf et al., 2013b), renew by local prolifer-
ation (Ajami et al., 2007), are responsible for surveying the CNS
parenchyma (Nimmerjahn et al., 2005) and aid in synaptic pruning
(Schafer et al., 2012). In injury, the microglia react immediately to
damage (Davalos et al., 2005) while macrophages enter the site
later in response to signals from injured tissues (Stirling and Yong,
2008). Those which induce macrophages to leave the blood vessel
including CCL7, IL-1 and TNF-beta do so indirectly through enhance-
ment of selectin expression on blood vessels (Takeshita and
Ransohoff, 2012). The microglia and monocyte-derived macro-
phages are historically difﬁcult to differentiate, as they express
many of the same markers including ED-1, Iba-1 and CX3CR1. They
can be crudely distinguished based on differing levels of CD45 or
CCR2 (David and Kroner, 2011) and differential susceptibility to
radiation (Matsumoto and Fujiwara, 1987).
Inﬁltrating macrophages can be divided into yet more subgroups: a
patrolling subgroup whose cells are Ly6c−, CX3CR1hi, CCR2lo cells and
the inﬂammatory subset, expressing Ly6c+, CX3CR1lo and CCR2hi
(Geissmann et al., 2003). Both of these cellular subtypes are found in
traumatic lesions, but their possible differential effects have not been
thoroughly studied. Phagocytic immune cells trafﬁc towards cytokines
secreted from injured tissue and can enter tissues after injury by extrav-
asation either during bleeding or by transmigration across blood vessels
using selectins expressed on the surface of endothelial cells. The best
known receptor ligand pairs for macrophage chemotaxis into damaged
tissues include CCR2 and its ligands CCL2/CCL7, CCR1/CCR5 and their
ligands CCL3/CCL5 and CX3CR1and its ligand, Fractalkine. Fractalkine
signals via contact-dependent interactions as a membrane molecule
and, after cleavage, at a distance. The functional roles of both CCR2
and CX3CR1 have been studied in spinal cord injury, but details about
their role in secondary dieback are lacking (Corona et al., 2010;
Donnelly et al., 2011; Ma et al., 2002).
In this study, we applied real-time, high-resolution, dynamic in vivo
imaging to characterize the close interactions that occur in vivo between
immune cells and axons during the secondary phase of axonal retraction
to determine whether dieback transpires in vivo as it does in vitro (Busch
et al., 2009). Using bone marrow chimeras, we show that blood-derived
Cx3cr1+/GFPmacrophages rather than Cx3cr1+/GFPmicroglia are responsi-
ble for secondary axonal damage after SCI via a contact mediatedmecha-
nism that results in thinning and breaking of the distal portion of the
axon. Since all cells causing destructive events appeared to be blood
derived Cx3cr1+/GFPwe have identiﬁed the blood-derivedmonocyte sub-
type as the cell type primarily involved in this interaction. In this model,
the axonal die back phenomenon was not dependent on the expression
of functional CCR2, implicating other signaling mechanisms, including
CX3CR1, for neuronal destruction by this patrolling monocyte subset.Materials and methods
Transgenic mice
Single, double and triple transgenic mice from the Thy-1YFP H
(Feng et al., 2000), Thy-1CFP (Feng et al., 2000), Cx3cr1+/GFP (Jung
et al., 2000) and Ccr2+/RFP (Saederup et al., 2010) lines were used.
All animals are on a C57BL6 background. Multiple transgenic lines
included the double transgenic lines Thy-1+/YFP H × Cx3cr1+/GFP
and Thy-1+/YFP H × Cx3cr1GFP/GFP and the triple transgenic lines
Thy-1+/YFP H × Cx3cr1+/GFP × Ccr2+/RFP and Thy-1+/YFP H ×Cx3cr1+/GFP ×
Ccr2RFP/RFP. We used adult mice from 8 to 20 weeks of age, with equal
numbers of male and female mice. Mice were housed and bred in the
animal resource center facilities at the CaseWestern Reserve University
according to standard husbandry practices. All experiments and animal
handlingwere performed in accordancewith protocols approved by the
Institutional Animal Care and Use Committee.
Chimeras
Bone marrow transplants were performed when host animals were
10–14 weeks of age. Animals were irradiated at 980 rads, and allowed
to rest for 4–5 h. Hosts received 3 million donor cells isolated from the
femur and tibia of donor animals by tail vein injection. Chimera
efﬁciency was veriﬁed in the blood 10 weeks post-transplant. Chimera
efﬁciency was established using ﬂow cytometry of blood collected
from these animals at 8–12 weeks after transplant. Details of ﬂow cy-
tometry experiments are found below in “Flow cytometry”. Chimerism
was determined by comparing the number of F4/80 and CX3CR1GFP
cells. Animals in which the host and the donor were the same genotype
were used as a comparison. In animalswith the samehost and donor, an
average of 40.36% CX3CR1GFP cells were found in the blood, with a low
of 36.0% and amaximumof 43.6%. In animalswith a CX3CR1GFP host and
B6 donor, the average percentage CX3CR1 positive cells found in the
blood was 0.58% and ranged from 1.4% to 0.1%. In animals with a B6
host and CX3CR1GFP donor, the average number of CX3CR1 positive
cells found in the blood was 38.73% and ranged from 30.8% to 54.2%.
The overall average efﬁciency of transplantation was 95.95%. Using a
two-tailed t-test assuming two samples of unequal variance, the P
value comparing transplanted animals with different host and donor
to those with the same genotype host and donor was *P b 0.00001.
Dorsal column crush (DCC) spinal injury model
Mice were anesthetized with inhaled isoﬂurane gas (2%) for all sur-
gical procedures. Amodiﬁed version of DCC spinal cord injury described
previously (Shen et al., 2009) was performed. Brieﬂy, a laminectomy
was performed to expose the T10 spinal cord segment. Small holes
were made in the dura 0.5 mm lateral to the midline with a 30 gauge
needle and a DCC lesion was made by inserting Dumont # 4 jeweler's
forceps approximately 1 mm into the dorsal spinal cord and squeezing,
holding pressure for 10 s and repeating two additional times. The
laminectomy site was covered with saline-soaked gelfoam (Pﬁzer)
and the muscle and skin closed. The animals received Marcaine
(1.0 mg/kg) subcutaneously along the incision site as well as
buprenorphine (0.1 mg/kg) intramuscularly. For sham surgeries, the
animals received a laminectomy and the intact dura was covered with
gelfoam.
In vivo imaging of the DCC lesion with two-photon microscopy
Intravital imaging was performed 0, 2, 4, 5 and 8 days after lesion
using a Leica SP5 confocal microscope ﬁtted with a 16 W IR laser
(Coherent, Inc.). To minimize artifacts from breathing and heartbeat,
the spine was stabilized using a STS-A small animal spinal cord holder
(Narishige International USA, Inc.) on a customized base. A well for
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clamps with OrthoJet dental acrylic (Lang Dental Manufacturing Co.,
Inc.). Vessels were labeled by tail vein injection of TRITC-dextran
(150,000 MW; Sigma). High-resolution 3D (xyz) images with a z-step
size of 3 μmwere taken of the top approximately 150 μm of the spinal
column. For each animal, mosaic images of the entire opened portion
of the spinal column were taken. Additionally, 1–6 hour-long
high-resolution 4D (xyzt) movies were acquired with a frame rate of
60 s/frame at the caudal side of the lesion where retraction bulbs are
found. If any evidence of thermal damage was observed, the samples
were not used. This included bubbling, changes in general structure of
the sample or swelling of the sample.
Flow cytometry
Five days after a DCC injury, Cx3cr1+/GFP animals were euthanized by
CO2 inhalation. Blood was collected by cardiac puncture and the spleen
and spinal cord were harvested. Each group consisted of 3 male mice.
20 μl of bloodwas incubatedwith heparin, the entire spleen and the sec-
tion of spinal cord including the DCC injury and 1mmrostral and caudal
to the lesion were treated with collagenase and placed on ice for 1 h.
Single cell suspensions of the spleens and spinal cords were generated
by pressing tissue through a 40 μm cell strainer (Corning) using the
plunger from a 1 ml syringe (BD) and suspended in PBS with 5%
serum (FACS buffer). Blood and tissue homogenates were red cell
lysed with ACK lyse (Life Technologies) 1–3 times or until the pellet
was no longer red in color, counted on a hemocytometer, and stained
with PE conjugated F4/80 antibody (eBioscience) at a concentration
of 1/100. Genetically expressed CX3CR1GFP was used to identify
CX3CR1+ cells. CD11b PE and CX3CR1GFP served as positive controls
for color compensation and an isotype control was also used for F4/80
(eBioscience). Samples were analyzed on an Accuri ﬂow cytometer
(BD Biosciences) using default ﬂow parameters. Analysis was
performed using CFlow Plus (BD Biosciences).
Sciatic nerve PhRodo injection
Animals received an injection of PhRodo-conjugated dextran
10,000 MW (Invitrogen) unilaterally into the sciatic nerve 6 days after
a DCC injury. Brieﬂy, the sciatic nerve of the right hind limbwas exposed
and crushed with #4 forceps. A 4–0 prolene suture was placed around
the nerve distal to the crush site, and a hole formed in the epineurium
distal to the suture with a 30-gauge needle through which a Hamilton
syringe was inserted and 1 μl of PhRodo-dextran (10% in water) was
injected into the crush site. Only animals where the crush site was suc-
cessfully ﬁlled with dye were used for the experiments. The suture was
tightened enough to prevent immediate backﬂow of dye through the
hole, but was not secured tightly around the nerve to avoid ligation of
the nerve and the animal was sutured closed. Animals received sub
cutaneous Marcaine (1.0 mg/kg) and intramuscular bupernex
(0.1 mg/kg) (Butler Schein). Animals were imaged as described
previously two days after sciatic nerve injection of the PhRodo dye.
Fixed spinal cord tissue analysis by immunoﬂuorescence histology
Double transgenic Thy-1+/YFP × Cx3cr1+/GFP or triple transgenic
Thy-1+/YFP × Cx3cr1+/GFP × Ccr2+/RFP and Thy-1+/YFP × Cx3cr1+/GFP ×
Ccr2RFP/RFP mice were perfused with PBS followed by 4% PFA in PBS. Ef-
ﬁcient perfusion was veriﬁed by blanching of the tissues. The tissue
was then post-ﬁxed in 4% PFA in PBS at 4 °C, embedded in OCT
compound and cut to 20 μm thick slices. Endogenous RFP, GFP and
YFP were used for imaging, and tissue was not counterstained with
anti-ﬂuorescent protein antibodies. Slides weremounted in Vectashield
anti-fade solution (Vectorlabs) and imaged with a Leica SP5 confocal
microscope (Leica).Image processing and statistical analysis
Image processing was completed using Imaris (Bitplane) to identify
axonal processes and track movement of cells. Mosaic images were
compiled using XuvStitch (www.xuvtools.org/). Cellular inﬁltration
and PhRodo inclusions were quantiﬁed via Imaris using the spots
function (Bitplane) to automatically identify cells based on quality
(greater than 1.2) and size of spots (greater than 6.7 μm in diameter).
These numbers were the optimum suggested values from Imaris.
Axonal dieback was quantiﬁed in 2D projections of mosaic images in
ImageJ by measuring from the leading edge of the proximal stump of
injured axons to the center of the lesion as identiﬁed by a line drawn
between the center of the two insertion sites for the two forceps tines.
“Destructive” events at the point of macrophage contact with the axon
were identiﬁed when the width of the axon measured at the initial
time of either cell contact or the initial point in our imaging session
decreased or increased in width by more than 50% over the imaging
session. Points of contact were identiﬁed by eye and measured only
after cell contact was observed. Data analysis was performed blinded
when possible, although data collection was not performed blinded
for practical reasons. Movies were compiled using AfterEffects
(Adobe). Statistical analysis was completed for the differences between
ﬁnal axonal positions, number of inﬁltrating cells, number of PhRodo
inclusions seen within Cx3cr1+/GFP cells and migration speeds of mono-
cytes and macrophages. In all cases, all tissue or images from a single
animal was considered an N of 1. For example, if 3 sections from the
same animal were used, this was considered an N of 1. All error bars
are standard error of the mean. Paired Student's T-tests were used for
all analyses in Excel (Microsoft). These tests are either single or double
tailed as noted and assumed two samples of unequal variance.
Results
The inﬂux of microglia and monocytes into the spinal cord lesion is closely
correlated with axonal dieback
First, we sought to examine the DCC lesion using intravital 2-photon
laser scanning microscopy. For these experiments, DCC was used since
this injury hasminimal functional impact on the animal and still enables
us to visualize and measure axonal retraction and immune cell inﬁltra-
tion. This model consisted of a laminectomy followed by a 1 mm ×
1 mm DCC injury to the dorsal columns at the T10 level (Fig. 1a). The
injury severs ascending sensory axonswhile leaving larger blood vessels
intact and minimizing ﬁbroblast invasion (Fig. 1b). To visualize axons,
monocytes and microglia at the site of injury in vivo without staining
procedures, we bred Thy-1+/YFP H mice (Feng et al., 2000) and
Cx3cr1+/GFPmice. To image these animals for all following experiments,
we re-opened the spinal column at the site of injury. Re-opening surger-
ies up to 8 days after injury to gain access for imaging proved to bemore
reliable and introduced less inﬂammatory cell inﬁltration at the surgical
site than chronic window implantation (data not shown).
This injury model reliably produced an easily quantiﬁable front of
axons that die away from the center of the crush (Fig. 1c), replicated
axonal dieback and inﬂammatory cell inﬁltration (Busch et al., 2009),
and produced the same end ball morphology as shown by Ramon y
Cajal (Cajal, 1907) (Fig. 1d). Axonal dieback was measured from the
leading edge of the proximal stump of the damaged axon to the center
of the crush site. The center of the site was identiﬁed as the line created
between the center of the two tines of the forcep insertion points. The
average difference in axonal position between 1 h after injury and
5 days after injury was 231.51 μm (Fig. 1e), concurrent with an inﬁltra-
tion of Cx3cr1+/GFP cells. Cx3cr1+/GFP cells increased in number at the
edges and centers of lesions and were in close proximity to the ends of
severed axons (Figs. 1c, f), roughly doubling in the ﬁrst two days, in-
creasing by 6 fold at day 5 and 9 fold at day 8. Results were not gender
dependent as male and female mice were used. Next, we veriﬁed that
Fig. 1.Axons die back from the site of injury andmacrophages inﬁltrate into a traumatic lesion of the dorsal columns indouble transgenic Thy-1 and CX3CR1GFP/+mice. a)Diagramof the
DCC injury. The red portion of the cord is damaged by a pinchingmotion of forceps. b) The DCC lesionwas easilymeasured in double transgenic Cx3cr1+/GFP (green) × Thy-1+/YFP (yellow)
animalswith blood vessels labeled by intravenous TRITC-dextran vessel dye injection (red). The lesion is located by the insertion points of the two forceps tines (dottedpink lines). A line is
then drawn between the centers of each insertion site to locate the center of the lesion (dotted orange line). Axon position is measured as the distance between axon tips and the orange
line (white lines). Scale bar= 200 μm. c) Imaging of the DCC lesion in four separate animals before injury and during the ﬁrst 8 days post injury reveals intact axons (yellow) in the dorsal
column before injury and axonal retraction bulbs at progressively longer distances from the center of the lesion over time. After injury, the axonal position at the edge of the injury site is
markedwith awhite dotted line. As time after injury increases, numbers ofCx3cr1+/GFP cells (green)within both the lesion border and the center of the lesion increase. Scale bar=100 μm.
d) Highermagniﬁcation of the end bulbs after injury, matching closely to those shown by Cajal (Cajal, 1907). e)Measurement of axon distances from center of DCC lesion. Axons die back
an average of 336 μmover the ﬁrst 8 days after injury. N= 3 at 0 and 2 days, N= 4 at 5 and 8 days. *P b 0.05, **P b 0.01, ***P b 0.001. f) Quantiﬁcation of Cx3cr1+/GFP cell inﬁltration into
center of DC lesion as in C. The number of CX3CR1+/GFPmacrophages and microglia increases steadily over the ﬁrst 8 days. N = 3 at 0 and 2 days, N = 4 at 5 and 8 days *P = b0.05 **P
b 0.0001, ***P b 0.0002 g) Example of ﬂow cytometry analysis of dissociated spinal cord 5 days after injury showing increased number of double positive, CD11b+ × Cx3cr1+/GFP cells
found in the injured spinal cord, but not in an animal with a sham laminectomy. h) Flow cytometry analyses from blood, spleen and dissociated spine of Cx3cr1+/GFP mice 5 days after
DCC injury compared to animals receiving a laminectomy but no injury. For both g and h, sample was gated to include all live cells in the sample of dissociated spinal cord. No additional
puriﬁcation steps were taken. Double positive Cx3cr1+/GFP / CD11b+ macrophage numbers remain the same in the blood and spleen but increased signiﬁcantly in the spine 5 days after
injury. Each condition was run in triplicate. * P b 0.05. All error bars are the standard error of themean. P values are derived using a two-tailed t-test for two samples of unequal variance.
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did not observe any adverse effects, Cx3cr1+/GFPmacrophage inﬁltration
or changes in Cx3cr1+/GFP cell morphology due to the imaging process
over several hours. Both axons and the ramiﬁed morphology of microg-
lia remained intact with no bubbling or increase in ﬂuorescence as typ-
ically seen with thermal damage (Supplemental movie 1). Immediately
after injury, time-lapse imaging revealed that Cx3cr1+/GFP cells began to
extravasate fromblood vessels and enter the lesion in theﬁrst hour after
injury (data not shown).
CX3CR1 and CD11b double positive cells increase in number in spinal cord
tissue after injury
To further verify the identity of Cx3cr1+/GFP cells within the lesion,
we performed ﬂow cytometric analysis of dissociated cells isolated
from an area 1 mm rostral and 1 mm caudal to the lesion of injured
and sham surgery spinal cords 5 days after injury. We veriﬁed the
identity of the Cx3cr1+/GFP cells by staining for CD11b/MAC1, a marker
for microglia, monocytes, macrophages and granulocytes in the CNS
(Babcock et al., 2003) (Fig. 1g). In the spinal cord, there was a 6-fold in-
crease in the number of double positive CD11b and GFP cells after injury
(Fig. 1h). Cell numbers were not statistically different in the blood of
DCC injured mice and sham animals (Fig. 1h).
Axonal dieback occurs by axotomy in the presence of Cx3cr1+/GFP
phagocytic cells
We next investigated whether we could directly visualize the cellu-
lar process by which axons die back away from the lesion site andwhether they lose parts of their retraction bulbs or retract into
themselves during secondary dieback as they do in vitro. Again, we
used double transgenic Thy-1+/YFP H × Cx3cr1+/GFP animals to identify
axons, macrophages, and microglia, and imaged mice 2, 5 and 8 days
after injury, during the period of secondary dieback. We observed large
numbers of cell contacts between Thy-1+/YFP axons and Cx3cr1+/GFP
cells. Surprisingly, some axon-macrophage contacts resulted in signiﬁ-
cant axonal morphologic changes and destruction during the 60 min
following their initial interaction. An example is shown in Fig. 2a and
Supplementary movie 2. We deﬁned a destructive contact as one that
causes a greater than 50% change in the width of the axon at the point
of contact. We also observed destructive axonal contacts at 22 days after
injury (Fig. 2b), indicating an ongoing process over a prolonged time
period. There were averages of 3.14 ± 1.04, 3.28 ± 0.79 and 3.47 ±
1.41 Cx3cr1+/GFP cell contacts per 200 μm of axon per hour on days
2, 5 and 8 after injury, respectively (Fig. 2c). In total, we observed 305
individual contacts, of which 11 were destructive during one to two
hour imaging sessions. Six of the destructive interactions resulted in ax-
onal thinning and ﬁve resulted in a complete severing of the axon dur-
ing the imaging session. These observations indicate that secondary
dieback in vivo takes place by axotomy via contact with a Cx3cr1+/GFP
cell. While there were many remnants of axons scattered about, the
small percentage of observed contacts that ended in destruction of
axons may be explained by the relatively short periods of observation
thatwere possible in these animals.Many of the contactswe sawduring
the imaging periodmay have potentially resulted in a destructive inter-
action at later time points. Also, we have not observed any destructive
events in axons without contact by a CX3CR1 positive cell, supporting
the hypothesis that these two events are related. In support of an axonal
Fig. 2. Cx3cr1+/GFP cells contact axons in the dorsal column after initial DCC injury at sites of axonal thinning and breaking. Examples of axons (yellow) interacting with Cx3cr1+/GFP cells
(green) at different times following DCC injury. Yellow axons are ascending dorsal column axons approaching the lesion. The lesion center is above the area shown. a) Example of inter-
action 5 days after DCC injury. Thinning and blebbing of the axon are marked by white arrows. Time stamp= h:min, total time 2 h. Scale bar = 20 μm. b) Example of an axonal cleavage
22days afterDCC injury. Cellularmaterial can be seen separating from the end of the dystrophic axon after contact by a Cx3cr1+/GFP cell (white arrow). This indicates that loss of axonal bits
is a continuing process even at later time points after injury. Time stamp= h:min. Total time: 1 h and 30 min. Scale bar = 20 μm. c) Quantiﬁcation of the rate of Cx3cr1+/GFP cell contact
with axons. Contacts were registered when a green Cx3cr1+/GFP cell remained less than 100 μm from an axon for more than 2min. A destructive contact was registeredwhen the width of
the axon changed by more than 50% at a location with Cx3cr1+/GFP cell contact. Once a contact between a Cx3cr1+/GFP cell was identiﬁed, the width of the axon at the time of contact was
measured in Imaris and compared to the width of the axon at the end of the imaging session or point where the contact ended, whichever came ﬁrst. Non-destructive contacts (hashed
bars) occurred more frequently than destructive ones, and increased on day 8 after DCC injury. Destructive contacts (black bars) were present in small numbers at 2, 5 and 8 days after
injury. We observed a total of 45 contacts and 2 destructive contacts in 1.3 h of imaging in 3 animals at 2 days after injury, a total of 162 contacts and 6 destructive contacts in 4.65 h
of imaging in 5 animals at 5 days after injury and total of 98 contacts and 3 destructive contacts in 5.4 h of imaging in 4 animals at 8 days after injury. Error bars are the standard error
of the mean. d) Image of the lesion near axonal retraction bulbs at 5 days after injury. Axons (yellow), Cx3cr1+/GFP cells (green) and the dorsal vein (V, labeled with TRITC-dextran,
red) can be seen. Yellow bits of axon material (arrows) can be seen in the lesion along the path that axons would have retracted along. These yellow inclusions are commonly seen
along the edges of the lesion near retracting axons and appear to be parts of axons left behind during the process of axonal retraction. Scale bar = 50 μm.
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of axonal dieback and within the lesion. An example at 5 days after in-
jury is shown (Fig. 2d).
Cx3cr1+/GFP cells phagocytize parts of once intact axons
Next, we investigated whether initially intact portions of the dam-
aged axon can be eventually phagocytized by Cx3cr1+/GFP cells between
days 6 and 8 after DCC injury, at the time when a large portion of die-
back takes place. We employed the pH-sensitive PhRodo-dextran con-
jugated dye (Invitrogen), which becomes ﬂuorescent only in a low pH
environment such as that found within lysosomes to identify phagocy-
tized axonal structures. Use of the pH-sensitive red dye allowed us to
separate inclusions within the GFP positive cells that were derived
from phagocytosis of once intact dystrophic axonal ends from phagocy-
tosis of debris generated during the formation of the lesion or debris
from the portion of the axon undergoing Wallerian degeneration or
from accidental detection of ﬂuorescence in the yellow channel from
very bright GFP emission. PhRodo-dextran (10 kD MW) was injected
into the sciatic nerve unilaterally on day 6 after DCC injury (Fig. 3a).
Two days later we observed puncta of ﬂuorescent PhRodo dye withinCx3cr1+/GFP cells located on the same side of the spinal cord as the sciatic
nerve injection (Figs. 3b and c). The average number of puncta on the
side of injection was 43 ± 2, compared to 17 ± 10 puncta on the
contralateral side (P b 0.05). Contralateral puncta may be in cells that
migrated across themidline. Red puncta found outside the parenchyma
of the spinal cord were excluded. Puncta within the spinal cord outside
of CX3CR1+/GFP cells were not observed. We also observed Thy-1+ in-
clusions within the cytoplasm of Cx3cr1+/GFP cells, indicating that
phagocytic uptake of axonal remnants by Cx3cr1+/GFP cells is not solely
restricted to those containing PhRodo-dextran (Figs. 3d, e).
Blood-derivedmonocytes comprise themajority ofmobile Cx3cr1+/GFP cells
within the lesion
Sincemicroglia are resistant to irradiation, andnumbers of Cx3cr1+/GFP
cells that can enter the CNS after irradiation are proportionately small
(Ajami et al., 2007), we used a bone marrow chimera animal approach
designed to distinguish the involvement of spinal cord-residentmicrog-
lia or bone marrow-derived cells to observe the differences between
these two cell types in vivo (Fig. 4a). Two variations of irradiation chi-
mera animals were used. In the ﬁrst, the host animal expressed Thy-
Fig. 3. CX3CR1+ cells phagocytize the ends of damaged dorsal column axons attached to the neuronal cell bodies in the dorsal root ganglia. a) Experimental scheme is depicted.
PH-sensitive PhRodo-conjugated dextran (10,000 MW) was injected into the sciatic nerve unilaterally on day 6 following DCC injury. The dye was then taken up in the crushed sciatic
nerve neurons and carried rostrally inside the neuron through the dorsal column to the site of DCC injury (yellow). The dye ﬂuoresces red after phagocytosis and inclusion in a low pH
lysosome. This allows us to distinguish axonal debris take up by macrophages that is removed from the ends of axons between days 6 and 8 from debris from the initial injury or from
distal axons undergoingWallerian degeneration. b) The PhRodo dyewas seen inside Cx3cr1+/GFP phagocytic cells locatedwithin DCC lesion ipsilaterally to the sciatic injection. The average
number of puncta on the side of injection was 43 ± 2, compared to 17 ± 10 puncta on the contralateral spine. c) Reconstruction of a Cx3cr1+/GFP cell seen in Fig. 3B with PhRodo dye
inclusions, showing that these inclusions are within the green Cx3cr1+/GFP cells. d) Quantiﬁcation of PhRodo inclusions in vesicles on the contralateral and ipsilateral side of the animal
to dye injection.We observed a total of 53 inclusions on the ipsilateral side to injection and 25 inclusions on the contralateral side in a total of 3 Cx3cr1+/GFPmice. Error bars are standard
error of themean. *P b 0.05 using a two-tailed t-test assuming two samples of unequal variance. E) In the absence of PhRodo injection and sciatic nervemanipulation and any correspond-
ing conditioning effects, Thy-1YFP inclusions (white) can also be found within Cx3cr1+/GFP cells (green) near dystrophic axon ends (white) 5 days following DCC injury without manipu-
lation of the sciatic nerve. CX3CR1+ cells were found along the ends of dystrophic axons. f) A single Cx3cr1+/GFP cell (green) with Thy-1YFP inclusions (white) shown in E. X, Y and Z
projections are shown, as well as a reconstruction of this cell showing the white inclusions within the Cx3cr1+/GFP cell.
114 T.A. Evans et al. / Experimental Neurology 254 (2014) 109–1201YFP and the donor animal was heterozygous for Cx3cr1GFP, allowing us
to identify GFP+macrophages. In the second, the host animal expressed
both Thy-1YFP and was heterozygous for Cx3cr1GFP and the donor was a
C57BL6 animal expressing no ﬂuorescent proteins, allowing us to iden-
tify resident microglia. We also used a Thy-1+/YFP host with a double
transgenic Cx3cr1+/GFP and Ccr2+/RFP donor to identify two lineages of
blood-derived monocytes/ macrophages (Geissmann et al., 2003). We
also checked for chimera efﬁciency at replacing monocytes in the
blood of transplantedmice, conﬁrming an average efﬁciency of replace-
ment of 96% of the host Cx3cr1+/GFP blood cells with those from the
donor (See Materials and methods for details). Spinal cord injury was
performed 8–12 weeks after bone marrow transplantation to allow
the immune system time to fully reconstitute. Using this approach, we
did not observe any differences in the extent of axonal dieback or in
the morphology of microglia, monocytes or axons within the lesion
(Figs. 4b, c). At 2 h, 2 days, 5 days and 8 days after injury, we observed
a large increase in blood-derived Cx3cr1+/GFP cells with very little in-
crease in the Cx3cr1+/GFP resident cell population (Figs. 4d and e). We
found that resident microglia appeared larger and more complex than
monocytes and had simple extended processes, whereas monocytes
were round (Fig. 4d). In the ﬁrst hours after injury, we saw an insignif-
icant difference between resident and inﬁltrating cells from that in the
uninjured animal. Blood-derived cells increased by 3 fold from day 0
to 2 and 7 fold from day 0 to 8. There was no signiﬁcant difference in
the amount of resident cells at any time point after initial injury
(Fig. 4e). These ﬁndings are in concordance with previous studies in
contusion models in rat bone marrow chimeras and other models(Mawhinney et al., 2012; Popovich and Hickey, 2001; Popovich et al.,
2003). Although irradiation of the spinal cord may attenuate prolifera-
tion of resident cells, these data revealed that the major increase in cel-
lularity in the spinal lesion was attributed to inﬁltrating Cx3cr1+/GFP
cells.
Monocyte-derived macrophages, not resident microglia, are responsible for
secondary axotomy
Next, we looked to see if any behavioral properties varied between
resident and inﬁltrating Cx3cr1+/GFP cells. Migratory capabilities of ei-
ther monocytes or macrophages within traumatic spinal cord lesions
have not been described previously. Using the same chimeric animals
described in Fig. 4A, we observed differences in the speed and displace-
ment of migration between blood-derived monocytes and resident mi-
croglia. The main population of Cx3cr1+/GFP cells within the lesion was
composed initially of resident microglia that showed morphological ac-
tivation.Within theﬁrst hour following injury, a small number of blood-
derived Cx3cr1+/GFP cells began to extravasate from the blood vessels
into the lesion, while residentmicroglia exhibited very little movement,
as shown by tracks (Figs. 5a–c, Supplementary movie 3). A higher mag-
niﬁcation of the movements of two blood-derived cells is shown in
Fig. 5B. From the dynamic images, we measured speed and displace-
ment. In the ﬁrst hour and 8 days after injury the average speed of
cord-resident microglia was 0.030 ± 0.0014 μm/s and 0.037 ± 0.0017,
respectively, while these same measurements for blood-derived
Cx3cr1+/GFP cells were 0.06 ± 0.0008 μm and 0.061 ± 0.0008 (Fig. 5d).
Fig. 4. The bulk of CX3CR1+ cells within DCC lesion are blood-derived. a) A schematic diagram of the bone marrow chimeric mice approach to allow for the distinction of blood-derived
monocyte-lineagemacrophages from residentmicrogliaCx3cr1+/GFP cells. Recipientmicewere irradiated, reconstitutedwith donor-derived bonemarrow cells and then allowed to rest for
8–12 weeks before imaging. Cx3cr1+/GFP × Thy-1 YFP/+animals received wild type B6 bone marrow, and Thy-1 YFP/+ animals received CX3CR1+ bone marrow, allowing only microglia or
only blood-derived cells to be CX3CR1+. b) Quantiﬁcation of post-DCC axonal dieback in chimeric animals 8–12 weeks after transplant revealed no signiﬁcant rate difference. All condi-
tions have Ns of between 2 and 7. The average N is 4. A total of 639 axons in 98micewere imaged. c) Comparison of microglia in chimeric animals with a Cx3cr1+/GFP host and a B6 donor
and Cx3cr1+/GFP animals shows similarmorphology. Scale bar is 50 μm. Non-signiﬁcance was determined using a two-tailed t-test assuming two sample of unequal variance. d) Images of
the caudal aspect of the DCC lesion in Thy-1YFP/+ chimeric animals with either labeled host or donor Cx3cr1+/GFP cells as compared to non-chimeric, un-irradiated double transgenic
Thy-1YFP× Cx3cr1+/GFP animals. Theﬁrst column shows animals with Cx3cr1+/GFP hosts and B6 donors, showing residentmicroglia. Small numbers of Cx3cr1+/GFP positive cells are present
in the lesion at all time points. The center column shows animals with Cx3cr1+/GFP donor cells, showing blood-derived Cx3cr1+/GFPmonocytes and macrophages that rapidly increase in
number with increasing time after injury. The right column shows non-chimeric double transgenic Thy-1YFP × Cx3cr1+/GFP animals. e) Quantiﬁcation of cell numbers in the center of the
lesion in E revealed consistently few microglia (hashed bars), but a dramatic increase in monocyte-derived cell number (black bars) over 8 days. Microglia numbers remain stable over
time, and inﬁltrating macrophages increase dramatically over time. All conditions have Ns of between 2 and 7. The average N is 4. Number of microglia and macrophages at the same
time point are statistically different at days 2 and 8 after injury. *P b 0.02 using a one tailed T-test assuming two samples of unequal variance.
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of cord-residentmicroglia was 4.47 ± 0.22 μm and 5.51± 0.40, respec-
tively, while these same measurements for blood-derived Cx3cr1+/GFP
cells were 15.4 ± 0.32 μm and 14.35 ± 0.40 (Fig. 5e). In the images
shown in a and c, differences in directionality of blood-derived cell
movement can be observed through the time-coding of cell position
shown by the changing color of the tracks. Using this coding, the earliest
times in imaging are identiﬁed as blue and the latest time points are
identiﬁed as white. In the ﬁrst hour after injury, cells were primarily lo-
calized within the vessel lumen at the beginning of the imaging period
and were seen to migrate from the blood vessel and into the lesion by
the end of the 60-minute imaging period (Fig. 5a). No directional migra-
tion of cells towards either the proximal or distal portion of the lesion
was noticed. This migration from the dorsal vein in the spinal cord
was only seen immediately after injury. At later time points, there was
a decrease in cell migration within the perivascular region and an in-
crease in migration within the center of the lesion. No directionality or
focus of movement of cells within the center of the lesion at these
later time points was noted, or expected due to the amount of tissuedamage seen throughout the lesion (Fig. 5c). Directionality of move-
ment was also difﬁcult to assess due to movement of cells into and out
of the ﬁeld of view and large populations of stationary or near stationary
CX3CR1+/GFP cells.
Next, we observed the cell contacts between these blood-
derived and resident Cx3cr1+/GFP cells within the lesion in the chime-
ric animals to see if a subset of these was responsible for destructive
contacts. In one case, we observed a quickly moving Cx3cr1+/GFP
cell at the lesion edge contacting an axon in two places, in each
case with a destructive effect (Fig. 6a and Supplementary movie
4). In another example, the axon was completely severed
(Fig. 6b). We did not observe any destructive changes where mi-
croglia contacted axons (Figs. 6c, e). We observed a total of 232
contacts and 22 destructive contacts in 10 Cx3cr1+/GFP→WT chi-
meric mice (Figs. 6a, b and d). We observed a total of 52 contacts
and no destructive contacts in 11 WT → Cx3cr1+/GFP chimeric
mice (Figs. 6 c and e). These data indicate that destructive contacts
largely, but perhaps not entirely, occur between blood-derived cells
and axons.
Fig. 5. Blood-derived CX3CR1+ cells have greater average speed and displacement than resident microglia. a) Immediately after DCC lesion, Cx3cr1+/GFPmicroglia move only very short
distances, while blood-derived cells traversed over great distances within the center of the lesion. Cell tracks are shown as color-coded time stamps (blue: time = 0 min; yellow:
time =60min; gradient shown in the ﬁgure). Both tracks andﬂuorescence are shown in images on the left, and only tracks in images on the right. Scale bar= 50um. Total time for track-
ing is 1 h. b) High-magniﬁcation sequential images of a onemacrophage's track andmovement in a. Scale bar= 7 um. Time stamp: h:min. Total time shown is 28min. c) 8 days after DCC,
only a few stationary microglial cells were found within the lesion 8 days following DCC injury. In comparison, blood-derived cells traveled over greater distances near the lesion. Both
tracks and ﬂuorescence are shown in images on the left, and only tracks in images on the right. Time stamp is the same as in a. Scale bar = 50um. d) In the ﬁrst hour after injury and
at 8 days after injury, monocytes and macrophages have a higher average speed than microglia. Each track was assessed for average speed. Tracking results were obtained from 228 mi-
croglia and 1601 monocytes/macrophages cells in three animals for each condition *P b 0.00001. e) In the ﬁrst hour after injury and at 8 days after injury, monocytes and macrophages
have a larger average displacement than microglia. Tracking is from 228 microglia and 1601 monocytes/macrophages cells in three animals for each condition *P b 0.00001.
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position after injury is not dependent on CCR2 expression
To further clarify the identity of inﬁltrating CX3CR1 phagocytic
cells, we took advantage of differential expression of CCR2 and
CX3CR1 that can identify different subsets of circulating macro-
phages (Mahad et al., 2006; Saederup et al., 2010). We did not ob-
serve any destructive events in axons outside of CX3CR1 positive
cell contact, so we looked in ﬁxed tissue sections to see if these
CX3CR1 positive blood-derived cells were also CCR2 positive. To
this end, we generated chimeric animals with a Thy-1+/YFP host
and Ccr2+/RFP × Cx3cr1+/GFP marrow donor. In ﬁxed sections from
the transplanted animal in which we were able to observe CCR2
RFP using confocal imaging, CX3CR1 and CCR2 ﬂuorescence was re-
stricted to only blood-derived monocytes and macrophages but not
microglia. Both Ccr2+/RFP cells and Cx3cr1+/GFP cells were blood de-
rived and capable of inﬁltrating into the lesion following spinal trau-
ma, while virtually no Ccr2+/RFP cells were found at sites away from
the lesion. Ccr2+/RFP cells were round in appearance resembling
monocyte morphology while Cx3cr1+/GFP cells were larger with
granular cytoplasm consistent with tissue phagocytes in both thenormal and transplanted animals (Fig. 7a). The inﬁltrating cells
comprise three populations in the chimeric animals. CCR2 single
positive cells comprised the largest population, followed by
CX3CR1 single positive cells. There was also a very small population
of double positive cells within the lesion (Fig. 7b), possibly com-
prised of CCR2 cells that are in the process of down regulating
CCR2 and upregulating CX3CR1 as macrophages mature. Since we
observed destructive contacts with Cx3cr1+/GFP positive cells
(Figs. 2, 6) and the double-labeled inﬁltrating cells were a small
minority (Fig. 7b), we speculate that destructive contacts were initi-
ated by the subgroups of inﬁltrating cells that are Cx3cr1+/GFP posi-
tive, and not those that are Ccr2+/RFP single positive. This was not
directly tested due to the dimness of CCR2RFP/+ cells in our live im-
aging set-up. Next, to verify that these CCR2 positive cells are unlike-
ly to be involved in axonal dieback, we looked at the axonal position
5 days after DCC in triple transgenic Thy-1YFP, CX3CR1GFP/+ and ei-
ther CCR2RFP/+ or CCR2RFP/RFP animals (Figs. 7c, d). In this case, we
did not see any difference in axonal position when measured from
the leading edge of the proximal stump of the axon leading up to
the injury (Fig. 7e), indicating that CCR2 is not directly necessary
for axonal dieback.
Fig. 6.Axonal destruction occurs in response to contact onlywith Cx3cr1+/GFP blood-derived cells and not Cx3cr1+/GFPmicroglia. a) Example of contact between a Thy-1CFP/+ axon (yellow)
and a Cx3cr1+/GFP blood-derived cell (green) resulting in axonal “blebbing” (white arrows) on day 5 after DCC injury. Blebbing occurred in two locations of the axon (yellow). b) Another
example of a contact between a Thy-1YFP/+ axon (yellow) and a Cx3cr1+/GFP blood-derived cell (green) resulting in axonal breakage (white arrows) on day 8 after DCC injury. c) Example of
the interactions betweenmicroglia (green) and an axon (yellow) on day 8 after DCC injury. No change in axonal size or integrity was observed during an hour-long imaging session. Colors
here are different than in A and B to allow easier identiﬁcation of yellow axons. d) Quantiﬁcation of contacts between axons and blood-derivedmacrophages, with steady numbers of con-
tacts and destructive contacts between axons and monocytes/macrophages seen on days 2, 5 and 8. We observed a total of 232 contacts and 22 destructive contacts in 10 blood-derived
Cx3cr1+/GFPmice. e) Quantiﬁcation of contacts between axons and residentmicroglia, with contacts but no destructive contacts seen on days 2, 5 and 8.We observed a total of 52 contacts
and no destructive contacts in 11 resident Cx3cr1+/GFPmice.
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Mechanism of secondary dieback by axonal membrane loss
We observed that axonal retraction during the secondary injury
phase occurs via multiple axotomies along the distal portion of injured
stalled axons which, in turn, results in the removal of the end of the
axon, creating a new axonal end. In contrast to this, in vitro activated
macrophages caused retraction of dystrophic axons over a long distance
in a manner involving rapid dissolution of the axonal cytoskeleton,
causing the distal axon to rapidly retract into itself (Horn et al., 2008).
This difference in mechanism is not surprising, as neuron behavior
in vitro occurred without the inﬂuence of extracellular matrix and sur-
rounding support cells. Similar axotomy and loss of axonal membrane
during dieback instead of axonal involution has been proposed to
occur in the CNS parenchyma following several other models of injury
wheremacrophages interactwith injured axons. These include zymosan
injection (Fitch and Silver, 2008) and traumatic brain injury (Greer et al.,
2013). Furthermore, our real-time observations of blebbing and loss of
membrane from axonal ends is consistent with the suggested pattern
of axonal dieback in the cortex after an ischemic stroke, where axonal
debris is found at the location where the uninjured axon was present
before the axon retracted towards its cell body and away from the site
of injury (Hawthorne et al., 2011). Axonal thinning has also been
shown in models of EAE (Powers et al., 2012). Our observations provide
further distinction between the initial phase of axonal retraction that is
cell intrinsic and decreased in the Wallerian degeneration slow mouse
(Kerschensteiner et al., 2005) and the secondary, inﬂammatory phase
of retraction.
Removal of membrane from axonal ends may have increased signif-
icance in the context of sprouting and attempted regrowth of axons
within the core of the lesion. Axonal ends in the lesion are not stationary
(Busch et al., 2009) and attempt to sprout in the ﬁrst few days to weeksafter injury (Kerschensteiner et al., 2005) largely in association with
NG2 glia whose surface is preferred by dystrophic axons and upon
which the dystrophic axon tips eventually stabilize and form synaptic-
like connections (Busch et al., 2010; Filous et al., 2013). It is possible
that activated macrophages, in addition to causing axonal dieback at
early stages, may also be involved in curtailing the ability of axons to
sprout. It is also possible that macrophages move from neuron to neu-
ron over a longer time period, removing membrane continually in a
fashion similar to the process of synaptic pruning that occurs during de-
velopment (Schafer et al., 2012, 2013).
Since inﬁltrating cells appear to be damaging,we looked at CCR2 and
CX3CR1 markers in ﬁxed tissue to differentiate monocytes expressing
these two chemokine receptors (Saederup et al., 2010). The CCR2hi/
CX3CR1lo population of monocytes differentiates into macrophages or
dendritic cells, while the CCR2lo/CX3CR1hi population may aid in
wound healing and other functions (Geissmann et al., 2003). Although
speculative, it appears that the CCR2+/RFP cell population is less likely
to be involved in dieback aswe have not seen axonal destruction events
that are not associatedwith contact by a Cx3Cr1+/GFP cell. Therefore, since
few Cx3Cr1+/GFP cells are also CCR2+/RFP positive, we can infer that these
cells are less likely to be involved in destructive events. This supports
the idea that there are subtypes of macrophages that may be more or
less harmful during trauma, and increasing the population that does
not cause destruction may be therapeutic (Kigerl et al., 2009). The dis-
tinction between these subtypes of macrophages and microglia is espe-
cially interesting, since it supports the idea that microglia are involved
primarily in maintaining CNS homeostasis, and continue to perform
such functions even after a traumatic injury (Davalos et al., 2005).
Separating the two main Cx3cr1+/GFP positive monocyte and
microglial cell lineages in the spinal cord presents a technical challenge.
Most models to-date involve manipulation of the animals, which could
cause potential permanent changes in the CNS cellular architecture.
These manipulations included an in utero transplantation chimera
Fig. 7. Very fewmacrophages are both Cx3cr1 +/GFP and Ccr2+/RFP positive. Residentmicroglia are primarily Cx3cr1 +/GFP, while blood-derivedmacrophages consist of populations of both
Cx3cr1+/GFP positivemacrophages and Ccr2+/RFP positivemacrophages. Axonal position after dieback is not affected byCCR2 deﬁciency. Since all instances of axon thinning and breaking in
in vivo imaging were in contact with a Cx3cr1+/GFP cell, we wanted to see if these cells are part of the same or different population than CCR2+ macrophages. a) Compiled immunoﬂuo-
rescence images of a DCC lesion (solid white box) 5 days after injury in ﬁxed, sectioned tissue in a Thy-1+/YFP (white) × Cx3cr1+/GFP (green) × Ccr2+/RFP (red) triple-reporter mouse.
A caudal region containing degenerating axons is marked with a dotted white box. Cx3cr1+/GFP and Ccr2+/RFP cells are found around the lesion. Scale bar is 200um. b) Quantiﬁcation of
Cx3cr1+/GFP (green) and Ccr2+/RFP (red) blood-derived cells found in the lesion in chimeric mice. Quantiﬁcation is performed in three slices in each of three mice. c) A triple transgenic
animal 5 days after DCC expressing Thy-1YFP, Cx3cr1+/GFP and Ccr2RFP/+. Scale bar = 100 μm. d) A triple transgenic animal 5 days after DCC expressing Thy-1YFP, Cx3cr1+/GFP and
Ccr2RFP/RFP. Scale bar = 100 um. e) Quantiﬁcation of axon position from the center of the lesion in these animals as described in the Materials and methods. N = 5 for each condition.
P = 0.10 using a one tailed t-test assuming samples of unequal variance. There is no difference between Ccr2RFP/+animals and Ccr2RFP/RFP animals, indicating that Ccr2 is also not singly
responsible for axonal position after injury. Since we only observed destructive events with Cx3cr1+/GFP cells in time-lapse imaging, and no difference in dieback is see in CCR2 deﬁcient
animals, we can infer that the Ccr2+/RFP cells, although present in the lesion, are unlikely to be responsible for these destructive events.
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et al., 2009), busulfan chimeras (Kierdorf et al., 2013a), parabiosis
(Ajami et al., 2011), macrophage depletion by clodronate liposomes
(Horn et al., 2008), and labeling of monocytes with CCR2RFP (Ma et al.,
2002; Saederup et al., 2010). None of these approaches, including
ours, are without caveats. Many of them are technically challenging
and may not have high enough efﬁciency to distinguish the two cell
types. Irradiation has also been shown to reduce microglial activation
for the ﬁrst week in the retina (Bosco et al., 2012), which may persist.
Busulfan is a chemotherapy drug that can be used to ablate host bone
marrow in place of irradiation. Busulfan chimeras have reduced inﬁltra-
tion into the CNS and blood brain barrier effects than irradiation
chimeras, although peripheral cell recruitment to the facial nerve after
axotomy is drastically reduced (Kierdorf et al., 2013a), making the
study of inﬁltrating cells more difﬁcult. Clodronate liposomes subject
the animal to inﬂammation associated with death of the cells (Van
Rooijen and Sanders, 1994), preventing simple observation in an other-
wise normal animal. In our hands we did not observe any irreparable
differences between control animals and bone marrow chimeras interms of the degree of axonal dieback or changes in cell morphology,
suggesting that our techniques are as minimally invasive as possible.
Further investigating knockout of chemokine receptors
In Ccr2RFP/RFP animals, a decrease in macrophage inﬁltration into tis-
sue has been observed in many models including corneal injury
(Oshima et al., 2006), EAE (Gaupp et al., 2003), toxoplasma gondii infec-
tion (Dunay et al., 2008) and neuropathic pain (Abbadie et al., 2003). In
cases where there is still some macrophage inﬁltration, there are also
other chemokines that may be able to compensate for loss of CCR2
(Gaupp et al., 2003). Again, we observed an inﬁltration of Cx3cr1+/GFP
and CCR2+/RFP cells into the lesion in CCR2 deﬁcient animals, and no
change in axonal position. In this case, it is likely that we do not see a
change in axonal position simply because the CX3CR1hi cells involved
in axonal dieback are still able to migrate into the lesion independent
of CCR2.
A second chemokine thatwill need to be investigated in the future is
CX3CR1, which is involved in monocyte motility and is the only known
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peripheral endothelial cells (Yona et al., 2013),. Varying degrees of dif-
ferences in disease progression and severity have been documented be-
tween Cx3cr1GFP/GFP and Cx3cr1+/GFP animals in a variety of mouse
models of disease and injury. These range from no difference in mouse
models of facial axotomy (Jung et al., 2000), to larger changes in
Alzheimer's disease (Bhaskar et al., 2010; Lee et al., 2010), spinal cord
injury (Donnelly et al., 2011), multiple sclerosis (Huang et al., 2006),
amyotrophic lateral sclerosis (ALS) and Parkinson's disease (Cardona
et al., 2006). Although not investigated here, a comparison of axonal
dieback between CX3CR1GFP/GFP and CX3CR1+/+ animals will be
instructive to the understanding of these cellular interactions. Future
experiments in another model of dieback, such as in the rat, where
greater retraction distances occur may be helpful (Horn et al., 2008).
Perhaps inhibiting more than one chemokine receptor at the same
time will add speciﬁcity to the well-established data suggesting that
global macrophage depletion can inhibit secondary dieback.Further investigating destructive cell types within the lesion
Even though we have identiﬁed Cx3cr1hi macrophages as the cell
population responsible for secondary axonal dieback,we have yet to de-
ﬁne the molecular signals involved in this process or the signiﬁcance of
the Cx3cr1lo and Ccr2hi cells in the lesion. Furthermore, the activation
state of the macrophage may also be important, as Cx3cr1+/GFP macro-
phages early on within the DCC lesion may be activated in a way that
promotes phagocytosis and removal of damaged tissues and potential
pathogens or later on in away that promotes healing and scar tissue for-
mation (Kigerl et al., 2009).
Many molecular signaling candidates involved in the macrophage–
dystrophic axon interaction have been proposed, including receptors
for phosphatidylserine (Titsworth et al., 2008) such as milk-fat globule
epidermal growth factor-like factor 8 (MFG-E8) (Li et al., 2012).
Signaling may also occur via changes in membrane permeability
through perforin or calcium-mediated processes (Coleman, 2005).
Blockade of proteases such asMMP9 has been used to prevent axonal
retraction in vitro, arguing that dieback may require protease action
between macrophages and dystrophic axons (Busch et al., 2009).
Chemotaxis may also be an important contributor in recruiting rele-
vant cells to the correct sites. Although we have determined that, in
this model, CCR2 is not necessary for this secondary axonal dieback
phenotype, other chemoattractants are likely involved. Further
investigation into what these signaling pathways are in traumatic
lesion is warranted, as well as the mechanism of interaction between
themacrophage and axon. Separating these two subpopulations of cells
and elucidating their roles in secondary damage will play a large role
when approaching more speciﬁc interventions for treatment of spinal
cord injury.
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